The research team of Prof. Lei Miao from Peking University has developed an efficient and low-toxic inhalable mRNA LNP for the treatment of chronic lung injury

Journal of Chinese Pharmaceutical Sciences ›› 2025, Vol. 34 ›› Issue (9): 894-894.

• News • Previous Articles Next Articles

The research team of Prof. Lei Miao from Peking University has developed an efficient and low-toxic inhalable mRNA LNP for the treatment of chronic lung injury

State Key Laboratory of Natural and Biomimetic Drugs, School of Pharmaceutical Sciences, Peking University Health Science Center

State Key Laboratory of Natural and Biomimetic Drugs, School of Pharmaceutical Sciences, Peking University Health Science Center

Received:2025-08-20 Revised:2025-08-20 Accepted:2025-08-20 Online:2025-10-02 Published:2025-10-01

Abstract

Supporting:

State Key Laboratory of Natural and Biomimetic Drugs, School of Pharmaceutical Sciences, Peking University Health Science Center. The research team of Prof. Lei Miao from Peking University has developed an efficient and low-toxic inhalable mRNA LNP for the treatment of chronic lung injury[J]. Journal of Chinese Pharmaceutical Sciences, 2025, 34(9): 894-894.

The research team of Prof. Lei Miao from Peking University has developed an efficient and low-toxic inhalable mRNA LNP for the treatment of chronic lung injury

PDF (PC)

Knowledge

Abstract

Cite this article

share this article

References

Related Articles 0

Recommended Articles

Metrics

Comments